Carboplatin (CBDCA), 5 fluorouracil (5-FU) and mitoxantrone (DHAD): an effective and well tolerated regimen for metastatic breast cancerHIDALGO, O. F; GONZALEZ, F. G; VIEITEZ, J. M et al.Annals of oncology. 1992, Vol 3, Num 7, pp 545-547, issn 0923-7534Article

Urokinase combination chemotherapy in small cell lung cancer : a phase II studyCALVO, F. A; HIDALGO, O. F; GONZALEZ, F et al.Cancer. 1992, Vol 70, Num 11, pp 2624-2630, issn 0008-543XArticle

Intraarterial chemotherapy with carboplatin and 5-fluorouracil in epidermoid cancer of the oropharynx and oral cavityVIEITEZ, J. M; BIOBAO, J. I; HIDALGO, O. F et al.Regional cancer treatment. 1991, Vol 4, Num 3, pp 152-155, issn 0935-0411Article

Simultaneous radiotherapy and cis-platinum for the treatment of brain metastases: a pilot studyHIDALGO, V; DY, C; HIDALGO, O. F et al.American journal of clinical oncology. 1987, Vol 10, Num 3, pp 205-209, issn 0277-3732Article

Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomasKUDOH, S; QIU WANG; HIDALGO, O. F et al.Cancer immunology and immunotherapy. 1995, Vol 41, Num 3, pp 175-184, issn 0340-7004Article

Intra-arterial hepatic treatment with carboplatin (CBDCA) and 5-fluorouracil (5-FU) in metastases from colorectal carcinomaHIDALGO, O. F; REBOLLO, J; VIEITEZ, J. M et al.American journal of clinical oncology. 1993, Vol 16, Num 1, pp 30-33, issn 0277-3732Article

Phase I trial of intermittent high-dose dacarbazine = Essai phase I du DTIC intermittent à haute doseBUESA, J. M; GRACIA, M; VALLE, M et al.Cancer treatment reports. 1984, Vol 63, Num 3, pp 499-504, issn 0361-5960Article